USR Reus-Tarragona

RESPONSABLE
avatar_investigadors.jpg
Enric Aragonès Benaiges
earagones.tgn.ics@gencat.cat
Reus-Tgn - USR equip

Publicacions

DRUG-RELATED PANCYTOPENIA AND LEUKOPENIA IN RHEUMATOID ARTHRITIS: ARE ALL CSDMARDS EQUAL?

L. CARMONA, J. WEAVER, E. BURN, B. ILLINGENS, D. VIZCAYA, R. SAWANT, T. DUARTE-SALLES, P. RYAN and D. PRIETO-ALHAMBRA
ANNALS OF THE RHEUMATIC DISEASES. 2020 Jun 1; . doi:10.1136/annrheumdis-2020-eular.4075;

  • Any: 01/06/2020
  • FI: 19.103
  • Article

TEMPORAL TRENDS OF OPIOID USE AMONG INCIDENT OSTEOARTHRITIS PATIENTS IN CATALONIA, 2007-2016: A POPULATION-BASED COHORT STUDY

J. XIE, A. TURKIEWICZ, G. COLLINS, M. ENGLUND, V. STRAUSS, C. REYES and D. PRIETO-ALHAMBRA
ANNALS OF THE RHEUMATIC DISEASES. 2020 Jun 1; . doi:10.1136/annrheumdis-2020-eular.3070;

  • Any: 01/06/2020
  • FI: 19.103
  • Article

CARDIO- AND CEREBROVASCULAR RISK WITH CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (CSDMARDS) IN RHEUMATOID ARTHRITIS (RA): A REAL-WORLD COMPARATIVE ASSESSMENT

A. PRATS-URIBE, B. ILLINGENS, D. VIZCAYA, J. WEAVER, E. BURN, R. SAWANT, K. MARINIER, P. RYAN and D. PRIETO-ALHAMBRA
ANNALS OF THE RHEUMATIC DISEASES. 2020 Jun 1; . doi:10.1136/annrheumdis-2020-eular.3463;

  • Any: 01/06/2020
  • FI: 19.103
  • Article

COMPARATIVE RISK OF CANCER ASSOCIATED WITH FIRST-LINE DMARDS USE IN RHEUMATOID ARTHRITIS: REAL WORLD EVIDENCE FROM THE OHDSI NETWORK

T. DUARTE-SALLES, M. RECALDE, J. WEAVER, E. BURN, K. MARINIER, Y. DIAZ, B. ILLINGENS, D. VIZCAYA, K. CHATZIDIONYSIOU, P. RYAN and D. PRIETO-ALHAMBRA
ANNALS OF THE RHEUMATIC DISEASES. 2020 Jun 1; . doi:10.1136/annrheumdis-2020-eular.3866;

  • Any: 01/06/2020
  • FI: 19.103
  • Article

GOUT IN SPANISH PRIMARY HEALHCARE CENTERS: STILL A LONG WAY TO GO

M. POU, S. JERIA, A. PRADA-OJEDA, S. FERRER, A. GARCIA-GUILLEN, H. COROMINAS and C. TORNE
ANNALS OF THE RHEUMATIC DISEASES. 2020 Jun 1; . doi:10.1136/annrheumdis-2020-eular.3117;

  • Any: 01/06/2020
  • FI: 19.103
  • Article

Patronat

Col·laboradors

Acreditacions